验证性多基因风险评分对中青年长期冠心病风险的预测效用
该研究基于FOS和ARIC队列中20-59岁无冠心病白人成人,比较传统风险因素评分与多基因风险评分(PRS)对30年冠心病风险的预测价值。结果显示PRS与传统风险因素评分均与冠心病发生显著相关,但将PRS加入传统风险因素模型后,C统计量仅小幅提升(青年组ΔC=0.03),中年组无改善。PRS作为不可干预因素,在传统风险模型基础上对长期冠心病预测的临床效用有限。
要点
- PRS与30年冠心病风险显著相关,但预测能力随年龄增长而减弱。
- 传统风险因素评分的区分度与PRS相似或更优。
- 在传统风险模型中加入PRS,青年组C统计量仅提升0.03,中年组无改善。
核心结论
- PRS与30年冠心病风险显著相关,但加入传统风险因素模型后C统计量仅边际改善,临床效用有限。
研究设计与样本
- 分析FOS和ARIC队列中20-59岁无冠心病且自报白种人的成人数据。
- 样本按年龄和队列分层:青年(FOS,20-39岁,中位30岁)、中年早期(FOS,40-59岁,中位43岁)、中年晚期(ARIC,45-59岁,中位52岁)。
主要发现
- 传统风险因素评分每1 SD的风险比在青年、中年早期、中年晚期分别为2.60(95%CI 2.08-3.27)、2.09(95%CI 1.83-2.40)、2.11(95%CI 1.96-2.28)。
- PRS的风险比在青年、中年早期、中年晚期分别为1.98(95%CI 1.70-2.30)、1.64(95%CI 1.47-1.84)、1.22(95%CI 1.15-1.30)。
- 传统风险因素评分的C指数在青年、中年早期、中年晚期分别为0.74(95%CI 0.70-0.78)、0.70(95%CI 0.67-0.72)、0.72(95%CI 0.70-0.73)。
- 年龄性别调整PRS的C指数在青年、中年早期、中年晚期分别为0.73(95%CI 0.69-0.78)、0.66(95%CI 0.62-0.69)、0.66(95%CI 0.64-0.67)。
- PRS加入传统风险因素评分后的ΔC指数在青年、中年早期、中年晚期分别为0.03(95%CI 0.001-0.05)、0.02(95%CI -0.002至0.037)、0.002(95%CI -0.002至0.006)。
临床怎么用
- 传统风险因素评分仍是长期冠心病风险预测的主要工具。
- PRS作为不可干预因素,在传统风险模型基础上临床效用有限,不建议常规用于中青年长期冠心病风险预测。
局限性
- PRS源自 predominantly 欧洲 ancestry 样本,仅纳入自报白种人,结果外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding the predictive utility of previously derived polygenic risk scores (PRSs) for long-term risk of coronary heart disease (CHD) and its additive value beyond traditional risk factors can inform prevention strategies. METHODS: Data from adults 20 to 59 years of age who were free of CHD from the FOS (Framingham Offspring Study) and the ARIC (Atherosclerosis Risk in Communities) study were analyzed. Because the PRS was derived from samples of predominantly European ancestry, individuals who self-reported White race were included. The sample was stratified by age and cohort: young (FOS, 20-39 years [median, 30 years] of age), early midlife (FOS, 40-59 years [median, 43] years of age), and late midlife (ARIC, 45-59 years [median, 52 years] of age). Two previously derived and validated prediction tools were applied: (1) a 30-year traditional risk factor score and (2) a genome-wide PRS comprising >6 million genetic variants. Hazard ratios for the association between each risk estimate and incident CHD were calculated. Predicted and observed rates of CHD were compared to assess discrimination for each model individually and together with the optimism-corrected C index (95% CI). RESULTS: Among 9757 participants, both the traditional risk factor score (hazard ratio per 1 SD, 2.60 [95% CI, 2.08-3.27], 2.09 [95% CI, 1.83-2.40], and 2.11 [95% CI, 1.96-2.28]) and the PRS (hazard ratio, 1.98 [95% CI, 1.70-2.30], 1.64 [95% CI, 1.47-1.84], and 1.22 [95% CI, 1.15-1.30]) were significantly associated with incident CHD in young, early midlife, and late midlife, respectively. Discrimination was similar or better for the traditional risk factor score (C index, 0.74 [95% CI, 0.70-0.78], 0.70 [95% CI, 0.67-0.72], and 0.72 [95% CI, 0.70-0.73]) compared with an age- and sex-adjusted PRS (0.73 [95% CI, 0.69-0.78], 0.66 [95% CI, 0.62-0.69], and 0.66 [95% CI, 0.64-0.67]) in young, early-midlife, and late-midlife participants, respectively. The ΔC index when PRS was added to the traditional risk factor score was 0.03 (95% CI, 0.001-0.05), 0.02 (95% CI, -0.002 to 0.037), and 0.002 (95% CI, -0.002 to 0.006) in young, early-midlife, and late-midlife participants, respectively. CONCLUSIONS: Despite a statistically significant association between PRS and 30-year risk of CHD, the C statistic improved only marginally with the addition of PRS to the traditional risk factor model among young adults and did not improve among midlife adults. PRS, an immutable factor that cannot be directly intervened on, has minimal clinical utility for long-term CHD prediction when added to a traditional risk factor model.
引用
- Khan SS, Page C, Wojdyla DM, et al. Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults. Circulation. 2022. PMID: 35880530. doi:10.1161/CIRCULATIONAHA.121.058426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。